EP 1482929 A1 20041208 - USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE
Title (en)
USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE
Title (de)
VERWENDUNG SUBSTITUIERTER 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOL-2-ONE ZUR HERSTELLUNG VON ARZNEIMITTELN MIT HEMMENDER WIRKUNG AN DER PANKREATISCHEN LIPASE
Title (fr)
UTILISATION DE 3-PHENYL-5-ALCOXY-1,3,4-OXDIAZOL-2-ONE SUBSTITUEE POUR LA FABRICATION DE MEDICAMENTS A EFFET INHIBITEUR SUR LA LIPASE PANCREATIQUE
Publication
Application
Priority
- DE 10208986 A 20020228
- EP 0301560 W 20030217
Abstract (en)
[origin: WO03072098A1] The invention relates to the use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-ones, in addition to their pharmacologically compatible salts and acid addition salts for producing medicaments, which exhibit an inhibiting action on pancreatic lipase, PL. The invention relates to the use of compounds of formula (I), in which the groups are defined as cited, in addition to their pharmacologically compatible salts and acid addition salts for producing a medicament for the prophylaxis or treatment of obesity or diabetes mellitus type 1 and 2.
IPC 1-7
IPC 8 full level
A61K 31/4152 (2006.01); A61K 31/4245 (2006.01); A61K 31/4439 (2006.01); C07D 271/10 (2006.01); A61K 31/454 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 45/00 (2006.01); A61P 3/02 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 43/00 (2006.01); C07D 413/08 (2006.01)
CPC (source: EP KR)
A61K 31/4245 (2013.01 - EP KR); A61P 3/02 (2018.01 - EP); A61P 3/04 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03072098 A1 20030904; AR 038702 A1 20050126; AU 2003210292 A1 20030909; BR 0308045 A 20041221; CA 2477005 A1 20030904; CN 1638766 A 20050713; CO 5611144 A2 20060228; DE 10208986 A1 20030911; EP 1482929 A1 20041208; HR P20040783 A2 20050430; HU P0500093 A2 20050428; IL 163719 A0 20051218; JP 2005519079 A 20050630; KR 20040101250 A 20041202; MA 27173 A1 20050103; MX PA04007480 A 20041110; NO 20044091 L 20040927; PL 371310 A1 20050613; RU 2004128932 A 20050410; TW 200400026 A 20040101
DOCDB simple family (application)
EP 0301560 W 20030217; AR P030100625 A 20030226; AU 2003210292 A 20030217; BR 0308045 A 20030217; CA 2477005 A 20030217; CN 03804767 A 20030217; CO 04083781 A 20040826; DE 10208986 A 20020228; EP 03742942 A 20030217; HR P20040783 A 20040827; HU P0500093 A 20030217; IL 16371903 A 20030217; JP 2003570844 A 20030217; KR 20047013470 A 20030217; MA 27804 A 20040727; MX PA04007480 A 20030217; NO 20044091 A 20040927; PL 37131003 A 20030217; RU 2004128932 A 20030217; TW 92103972 A 20030226